InvestorsHub Logo

Bobwins

03/29/19 9:31 AM

#10556 RE: swampboots #10532

ATE.v/ATBPF C$.28

https://stockhouse.com/news/press-releases/2019/03/29/antibe-therapeutics-announces-commencement-of-phase-2b-dose-ranging-efficacy

This should be a fairly short trial. Antibe did a similar study but with fewer participants. This trial is intended to define the optimum dosage for the crucial phase III trial that Antibe intends to partner with a big pharma company that will eventually market the final product.